Systemic sarcoidosis after treatment with pegylated interferon-alpha
A few cases of sarcoidosis have been reported in the course of chronic hepatitis C, with or without alpha-interferon treatment. We report a 54-year-old woman who presented a typical sarcoidosis in this context. The sarcoidosis involved skin, lungs and eyes. There are data in the literature supportin...
Gespeichert in:
| Veröffentlicht in: | La revue de medecine interne 2010-04, Vol.31 (4), p.e11-e13 |
|---|---|
| Hauptverfasser: | , , , , , , |
| Format: | Artikel |
| Sprache: | fre |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | e13 |
|---|---|
| container_issue | 4 |
| container_start_page | e11 |
| container_title | La revue de medecine interne |
| container_volume | 31 |
| creator | Le Bras, M Hervier, B Wastiaux, H Masseau, A Durant, C Jossic, F Hamidou, M |
| description | A few cases of sarcoidosis have been reported in the course of chronic hepatitis C, with or without alpha-interferon treatment. We report a 54-year-old woman who presented a typical sarcoidosis in this context. The sarcoidosis involved skin, lungs and eyes. There are data in the literature supporting a pathogenic link between alpha-interferon and sarcoidosis: alpha-interferon possessing a non-specific immunologic inductor. The treatment of the sarcoidosis in this context is difficult and has to be adjusted to both the severity of the sarcoidosis and the viral hepatitis. Although sarcoidosis induced by alpha-interferon is rare, clinicians must be aware of this association. |
| doi_str_mv | 10.1016/j.revmed.2009.03.366 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_733851877</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>733851877</sourcerecordid><originalsourceid>FETCH-LOGICAL-p554-12825d68700355fe8cd4b387858d050f6a626c7ff56158faf8378f87df4732e23</originalsourceid><addsrcrecordid>eNo1kEtLAzEUhYMgtlb_gcjsXM14k0wes5T6hIILux_SyY1NmZdJRum_d8C6Oovz8cE5hNxQKChQeX8oAn53aAsGUBXACy7lGVlSJXXOKWMLchnjAQBmurogCwZUcKjKJXn8OMaEnW-yaEIzeDtEHzPjEoYsBTSpwz5lPz7tsxE_j61JaDPfz7XDMPS5ace9uSLnzrQRr0-5Itvnp-36Nd-8v7ytHzb5KESZU6aZsFIrAC6EQ93Ycse10kJbEOCkkUw2yjkhqdDOOM2VdlpZVyrOkPEVufvTjmH4mjCmuvOxwbY1PQ5TrBXnWlCt1EzenshpN99Sj8F3Jhzr_938F67AWgA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>733851877</pqid></control><display><type>article</type><title>Systemic sarcoidosis after treatment with pegylated interferon-alpha</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Le Bras, M ; Hervier, B ; Wastiaux, H ; Masseau, A ; Durant, C ; Jossic, F ; Hamidou, M</creator><creatorcontrib>Le Bras, M ; Hervier, B ; Wastiaux, H ; Masseau, A ; Durant, C ; Jossic, F ; Hamidou, M</creatorcontrib><description>A few cases of sarcoidosis have been reported in the course of chronic hepatitis C, with or without alpha-interferon treatment. We report a 54-year-old woman who presented a typical sarcoidosis in this context. The sarcoidosis involved skin, lungs and eyes. There are data in the literature supporting a pathogenic link between alpha-interferon and sarcoidosis: alpha-interferon possessing a non-specific immunologic inductor. The treatment of the sarcoidosis in this context is difficult and has to be adjusted to both the severity of the sarcoidosis and the viral hepatitis. Although sarcoidosis induced by alpha-interferon is rare, clinicians must be aware of this association.</description><identifier>EISSN: 1768-3122</identifier><identifier>DOI: 10.1016/j.revmed.2009.03.366</identifier><identifier>PMID: 20153094</identifier><language>fre</language><publisher>France</publisher><subject>Female ; Humans ; Interferon-alpha - adverse effects ; Middle Aged ; Sarcoidosis - chemically induced</subject><ispartof>La revue de medecine interne, 2010-04, Vol.31 (4), p.e11-e13</ispartof><rights>Copyright 2010. Published by Elsevier SAS.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/20153094$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Le Bras, M</creatorcontrib><creatorcontrib>Hervier, B</creatorcontrib><creatorcontrib>Wastiaux, H</creatorcontrib><creatorcontrib>Masseau, A</creatorcontrib><creatorcontrib>Durant, C</creatorcontrib><creatorcontrib>Jossic, F</creatorcontrib><creatorcontrib>Hamidou, M</creatorcontrib><title>Systemic sarcoidosis after treatment with pegylated interferon-alpha</title><title>La revue de medecine interne</title><addtitle>Rev Med Interne</addtitle><description>A few cases of sarcoidosis have been reported in the course of chronic hepatitis C, with or without alpha-interferon treatment. We report a 54-year-old woman who presented a typical sarcoidosis in this context. The sarcoidosis involved skin, lungs and eyes. There are data in the literature supporting a pathogenic link between alpha-interferon and sarcoidosis: alpha-interferon possessing a non-specific immunologic inductor. The treatment of the sarcoidosis in this context is difficult and has to be adjusted to both the severity of the sarcoidosis and the viral hepatitis. Although sarcoidosis induced by alpha-interferon is rare, clinicians must be aware of this association.</description><subject>Female</subject><subject>Humans</subject><subject>Interferon-alpha - adverse effects</subject><subject>Middle Aged</subject><subject>Sarcoidosis - chemically induced</subject><issn>1768-3122</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2010</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNo1kEtLAzEUhYMgtlb_gcjsXM14k0wes5T6hIILux_SyY1NmZdJRum_d8C6Oovz8cE5hNxQKChQeX8oAn53aAsGUBXACy7lGVlSJXXOKWMLchnjAQBmurogCwZUcKjKJXn8OMaEnW-yaEIzeDtEHzPjEoYsBTSpwz5lPz7tsxE_j61JaDPfz7XDMPS5ace9uSLnzrQRr0-5Itvnp-36Nd-8v7ytHzb5KESZU6aZsFIrAC6EQ93Ycse10kJbEOCkkUw2yjkhqdDOOM2VdlpZVyrOkPEVufvTjmH4mjCmuvOxwbY1PQ5TrBXnWlCt1EzenshpN99Sj8F3Jhzr_938F67AWgA</recordid><startdate>201004</startdate><enddate>201004</enddate><creator>Le Bras, M</creator><creator>Hervier, B</creator><creator>Wastiaux, H</creator><creator>Masseau, A</creator><creator>Durant, C</creator><creator>Jossic, F</creator><creator>Hamidou, M</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>7X8</scope></search><sort><creationdate>201004</creationdate><title>Systemic sarcoidosis after treatment with pegylated interferon-alpha</title><author>Le Bras, M ; Hervier, B ; Wastiaux, H ; Masseau, A ; Durant, C ; Jossic, F ; Hamidou, M</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p554-12825d68700355fe8cd4b387858d050f6a626c7ff56158faf8378f87df4732e23</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>fre</language><creationdate>2010</creationdate><topic>Female</topic><topic>Humans</topic><topic>Interferon-alpha - adverse effects</topic><topic>Middle Aged</topic><topic>Sarcoidosis - chemically induced</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Le Bras, M</creatorcontrib><creatorcontrib>Hervier, B</creatorcontrib><creatorcontrib>Wastiaux, H</creatorcontrib><creatorcontrib>Masseau, A</creatorcontrib><creatorcontrib>Durant, C</creatorcontrib><creatorcontrib>Jossic, F</creatorcontrib><creatorcontrib>Hamidou, M</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>MEDLINE - Academic</collection><jtitle>La revue de medecine interne</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Le Bras, M</au><au>Hervier, B</au><au>Wastiaux, H</au><au>Masseau, A</au><au>Durant, C</au><au>Jossic, F</au><au>Hamidou, M</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Systemic sarcoidosis after treatment with pegylated interferon-alpha</atitle><jtitle>La revue de medecine interne</jtitle><addtitle>Rev Med Interne</addtitle><date>2010-04</date><risdate>2010</risdate><volume>31</volume><issue>4</issue><spage>e11</spage><epage>e13</epage><pages>e11-e13</pages><eissn>1768-3122</eissn><abstract>A few cases of sarcoidosis have been reported in the course of chronic hepatitis C, with or without alpha-interferon treatment. We report a 54-year-old woman who presented a typical sarcoidosis in this context. The sarcoidosis involved skin, lungs and eyes. There are data in the literature supporting a pathogenic link between alpha-interferon and sarcoidosis: alpha-interferon possessing a non-specific immunologic inductor. The treatment of the sarcoidosis in this context is difficult and has to be adjusted to both the severity of the sarcoidosis and the viral hepatitis. Although sarcoidosis induced by alpha-interferon is rare, clinicians must be aware of this association.</abstract><cop>France</cop><pmid>20153094</pmid><doi>10.1016/j.revmed.2009.03.366</doi></addata></record> |
| fulltext | fulltext |
| identifier | EISSN: 1768-3122 |
| ispartof | La revue de medecine interne, 2010-04, Vol.31 (4), p.e11-e13 |
| issn | 1768-3122 |
| language | fre |
| recordid | cdi_proquest_miscellaneous_733851877 |
| source | MEDLINE; Elsevier ScienceDirect Journals |
| subjects | Female Humans Interferon-alpha - adverse effects Middle Aged Sarcoidosis - chemically induced |
| title | Systemic sarcoidosis after treatment with pegylated interferon-alpha |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-07T12%3A40%3A36IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Systemic%20sarcoidosis%20after%20treatment%20with%20pegylated%20interferon-alpha&rft.jtitle=La%20revue%20de%20medecine%20interne&rft.au=Le%20Bras,%20M&rft.date=2010-04&rft.volume=31&rft.issue=4&rft.spage=e11&rft.epage=e13&rft.pages=e11-e13&rft.eissn=1768-3122&rft_id=info:doi/10.1016/j.revmed.2009.03.366&rft_dat=%3Cproquest_pubme%3E733851877%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=733851877&rft_id=info:pmid/20153094&rfr_iscdi=true |